We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
(+25%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$57.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$52.3M |
| 3 |
Micron Technology
MU
|
+$46M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
| 5 |
Apple
AAPL
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$76.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.9M |
| 3 |
NVR
NVR
|
+$49.7M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$37.5M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Prothena Corp
PRTA
$459M
| $4.98M | 0.05% |
314,325
+24,513
| +8% | +$263K |
|
|
AVID
377
DELISTED
Avid Technology Inc
AVID
| $4.97M | 0.05% |
579,286
+118,819
| +26% | +$875K |
|
|
TXNM
378
TXNM Energy Inc
TXNM
$6.45B
| $4.95M | 0.05% |
97,542
+16,627
| +21% | +$835K |
|
379
Powell Industries
POWL
$7.86B
| $4.94M | 0.05% |
302,373
+75,813
| +33% | +$1.06M |
|
380
AdvanSix
ASIX
$549M
| $4.91M | 0.05% |
246,156
+47,306
| +24% | +$1.03M |
|
381
Ally Financial
ALLY
$13.2B
| $4.81M | 0.05% |
157,536
-19,454
| -11% | -$607K |
|
382
Coherus Oncology
CHRS
$225M
| $4.81M | 0.05% |
267,150
+109,019
| +69% | +$2.01M |
|
383
Visteon
VC
$2.78B
| $4.8M | 0.05% |
55,470
+31,988
| +136% | +$2.85M |
|
384
American Public Education
APEI
$911M
| $4.78M | 0.05% |
174,544
+68,792
| +65% | +$1.68M |
|
|
SNBR
385
DELISTED
Sleep Number
SNBR
| $4.71M | 0.05% |
+95,704
| New | +$4.55M |
|
|
ABMD
386
DELISTED
Abiomed Inc
ABMD
| $4.7M | 0.05% |
+27,569
| New | +$5.11M |
|
387
Bank of America
BAC
$436B
| $4.66M | 0.05% |
132,330
-60,370
| -31% | -$1.95M |
|
|
MAGN
388
Magnera Corp
MAGN
$488M
| $4.66M | 0.05% |
19,587
+4,794
| +32% | +$1.07M |
|
|
DBD
389
DELISTED
Diebold Nixdorf Incorporated
DBD
| $4.64M | 0.05% |
439,011
+50,417
| +13% | +$448K |
|
|
OPB
390
DELISTED
Opus Bank Common Stock
OPB
| $4.61M | 0.05% |
178,017
+17,299
| +11% | +$428K |
|
391
PBF Energy
PBF
$7.28B
| $4.59M | 0.05% |
+146,192
| New | +$4.5M |
|
392
Diamondrock Hospitality Co
DRH
$2.64B
| $4.44M | 0.04% |
400,362
+119,271
| +42% | +$1.23M |
|
393
Medifast
MED
$108M
| $4.43M | 0.04% |
40,417
-14,843
| -27% | -$1.44M |
|
|
LSXMA
394
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $4.4M | 0.04% |
+126,077
| New | +$4.17M |
|
|
EBSB
395
DELISTED
Meridian Bancorp, Inc.
EBSB
| $4.39M | 0.04% |
218,364
+19,243
| +10% | +$377K |
|
396
Axsome Therapeutics
AXSM
$12.3B
| $4.39M | 0.04% |
42,438
-31,827
| -43% | -$1.29M |
|
397
Northwest Natural Holdings
NWN
$2.16B
| $4.37M | 0.04% |
59,231
-41,433
| -41% | -$2.86M |
|
|
RRD
398
DELISTED
RR Donnelley & Sons Co.
RRD
| $4.35M | 0.04% |
1,102,397
+680,691
| +161% | +$2.69M |
|
399
Wintrust Financial
WTFC
$10.8B
| $4.34M | 0.04% |
61,272
-15,205
| -20% | -$1.01M |
|
400
The Bancorp
TBBK
$2.82B
| $4.33M | 0.04% |
333,868
+33,282
| +11% | +$373K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2019 Portfolio in Review
As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.
- Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
- Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
- Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
- Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
- Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
- Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.